Fund: FTBDNCH
Franklin Templeton - Franklin Biotechnology Discovery Fund A(acc)CHF-H1 | |
LU0959058974 | |
16-08-2013 | |
Equity | |
Equity Sectors - Health Care | |
Franklin Templeton Investment Funds | |
Franklin Advisers, Inc. | |
Evan McCulloch | |
CHF | |
1,000 | |
5.75% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | 1.67% | 10.04% | 1.26% | 35.69% | 26.27% | -1.94% | 5.70% | 1.60% | 1.95% | N/A | |
Priemerná výkonnosť (36 meraní) | 0.06% | -4.90% | -2.31% | 0.36% | -0.11% | ||||||
Volatilita od priemernej výkonnosti | 9.18% | 29.28% | 7.47% | 4.96% | 3.48% |
Long | Short | Net | |
---|---|---|---|
Stock | 99.09% | 99.09% | |
Bond | |||
Other | 0.64% | 0.64% | |
Cash | 0.80% | 0.53% | 0.27% |
Aktíva | 22 mil. |
Počet akcíí | 86 |
Počet dlhopisov | 1 |
Priebež. popl. | 1.82 |
z toho Mng. popl. | 1.50 |
Výk. prémia | |
Trans. popl. | 0.08 |
Dividenda | |
Dividendový výnos | |
Rozhodný dátum | |
Frekvencia výplaty |
Giant | 2.97% |
Large | 26.07% |
Medium | 26.23% |
Small | 14.00% |
Micro | 26.40% |
P/E | 18.38% |
P/BV | 3.35% |
Basic Materials | 0.92% |
Healthcare | 96.00% |
Corporate | 0.64 |
Derivatives | 0.27 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
AAA | 0.00 |
AA | 55.65 |
A | 0.00 |
BBB | 0.00 |
BB | 0.00 |
B | 0.00 |
Below B | 0.00 |
Not Rated | 44.35 |
United States | 83.78% |
Canada | 0.78% |
Latin America | |
United Kingdom | 3.82% |
Eurozone | 4.53% |
Europe - ex Euro | 4.85% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | |
Australasia | |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 97.76% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Amgen Inc | Healthcare | 8.11% | Regeneron Pharmaceuticals Inc | Healthcare | 7.32% |
Vertex Pharmaceuticals Inc | Healthcare | 6.25% | Ascendis Pharma A/S ADR | Healthcare | 3.89% |
Insmed Inc | Healthcare | 3.69% | Biogen Inc | Healthcare | 3.37% |
Merus NV | Healthcare | 3.31% | Gilead Sciences Inc | Healthcare | 3.13% |
AstraZeneca PLC ADR | Healthcare | 2.97% | Intra-Cellular Therapies Inc | Healthcare | 2.75% |